Showing results (451-460 of 1,813) with videos related to

Sort By:
Pageof 182
Transplantation and Cellular Therapy|February 13, 2022
Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric PatientsRebecca Epperly, Aimee C Talleur, Ying Li, et al.
Transplantation and Cellular Therapy|February 14, 2022
Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for MyelofibrosisTania Jain, Hua-Ling Tsai, Amy E DeZern, et al.
Transplantation and Cellular Therapy|March 15, 2022
Pathogen-Specific Humoral Immunity and Infections in B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy Recipients with Multiple MyelomaSrirama Josyula, Margot J Pont, Sayan Dasgupta, et al.
Transplantation and Cellular Therapy|March 16, 2022
Prevalence of and Factors Associated with Marital Distress among Hematopoietic Cell Transplantation Survivors: Results from a Large Cross-Sectional StudyShelby L Langer, Jean C Yi, Karen L Syrjala, et al.
Transplantation and Cellular Therapy|March 18, 2022
Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States PopulationAndrew St Martin, Kyle M Hebert, Arnaud Serret-Larmande, et al.
Transplantation and Cellular Therapy|April 28, 2022
Healthcare Resource Utilization and Costs of Steroid-Associated Complications in Patients With Graft-Versus-Host DiseaseElizabeth J Bell, Jingbo Yu, Valkal Bhatt, et al.
Transplantation and Cellular Therapy|April 16, 2022
Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete RemissionEvgeny Klyuchnikov, Anita Badbaran, Radwan Massoud, et al.
Transplantation and Cellular Therapy|April 16, 2022
Socioeconomic and Racial Disparity in Chimeric Antigen Receptor T Cell Therapy AccessNausheen Ahmed, Moazzam Shahzad, Ernie Shippey, et al.
Transplantation and Cellular Therapy|April 12, 2022
Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular TherapyAmal Alseraihy, Eoin McGrath, Dietger Niederwieser, et al.
Transplantation and Cellular Therapy|April 4, 2022
Change in Neurocognitive Performance Among Patients with Non-Hodgkin Lymphoma in the First Year after Chimeric Antigen Receptor T Cell TherapyAasha I Hoogland, Anna Barata, Jennifer Logue, et al.
Pageof 182